Top Tweets for #ELIXR23
Here’s a great talk from @cusm_muhc very own Nicole Ezer MD #ELIXR23 - Update on lung cancer screening in Canada and beyond https://t.co/kM1BckKZI1 Join us for #ELIXR24 to discuss more on the future of lung cancer screening: https://t.co/4mQt88zqgZ
Watch Corinne Faivre-Finn MD PhD @finn_corinne deliver a talk on the state of the art for #RadOnc in stage 3 NSCLC #ELIXR23 - Tailoring radiation plans in the context of adv... https://t.co/nscWU7lnsH More to come from folks like @DrewMoghanaki and @AndrearicFili at #ELIXR24: https://t.co/7SrEoKq8Ls
Catch Patrick Forde MBBCh @FordePatrick discussing neoadj vs periadj when KN671 was hot off the press #ELIXR23 - Croque monsieur vs sandwich therapy: Is CM816 superio... https://t.co/fLgkKqlJ9C
He will be back with lots more great insights at #ELIXR24! Sign up to attend here: https://t.co/7SrEoKq8Ls
Here’s an awesome and almost futuristic talk from Lorenzo Ferri MD PhD @LFerri123 on patient avatars for personalized medicine #ELIXR23 - Organ chip-based drug testing platforms in oncology https://t.co/AI8pMUdexH Sign up for #ELIXR24 here: https://t.co/4mQt88zqgZ
Here’s a rare opportunity to get a master’s view of the adjuvant landscape from BR31 PI Glenwood Goss MD from @CDNCancerTrials speaking during #ELIXR23 - Making sense of the adjuvant landscape https://t.co/IcPG1mLjQW
Check out #ELIXR24 this June 13 and 14th: https://t.co/7SrEoKq8Ls
Here Philippe Joubert MD PhD @PJoubertPatho discusses spatial biology of cellular neighborhoods and their value for outcome prediction #ELIXR23 - Prediction of progression by multiplex molecular i... https://t.co/RZL2O9e42O
Plenty more on this subject if you attend #ELIXR24 from @loganawalsh https://t.co/7SrEoKq8Ls
Check out some of our presentations from #ELIXR23! Some really great talks that remain relevant and insightful. More of this kind of content and opportunity for networking if you decide to attend #ELIXR24 https://t.co/zUjMi4QtQB
Jessica Donington MD @jdoningtonmd - Ying vs Yang: Extended pulmonary resection + mini... https://t.co/Szxu9a21Zr
@DrSteveMartin @BrendonStilesMD @DoctorJSpicer @jdoningtonmd That’s me! @DoctorJSpicer & @NormandBlais actually put together an early morning support package in every hotel room for medical oncologists at #elixr23
Have a look at our product from #ELIXR23 to generate a Canadian consensus approach to resectable early-stage #NSCLC. An effort led by my amazing colleague @NormandBlais from @chumontreal and our remarkable alumnus thoracic surgery fellow @JamieTankel from @MThoracics @cusm_muhc! Contributions from a diverse Canadian team of experts including @drdavidpalma @DrAnnaMcGuire @biniamkidaneMD @HoudaBahig @pierrefiset @PJoubertPatho and many others not on X. @ThoracicsCanada
Proud to share my most recent and important publication to date. Under the amazing guidance of @NormandBlais and @DoctorJSpicer....transcanadian guidelines for Mx of stage II / III NSCLC!!
https://t.co/fW3hdm7Zcq
So wonderful to see @BorisSepesi on the podium sharing his extensive expertise in this domain and @paugalde20 with her excellent and unique take on the realties and challenges for patients with stage II resectable NSCLC! #ELIXR23 #LCSM @NormandBlais
Pros and cons, without debate, of neo-adjuvant vs adjuvant therapies in NSCLC as per @BorisSepesi and #DrPaulaUgalde . Major changes in the world needed to bring benefits to all patients #ELIXR23
@finn_corinne Thank you so much for lending your time and amazing expertise to our meeting! #ELIXR23 @NormandBlais
Thank you so much to @NormandBlais @DoctorJSpicer for a wonderful #ELIXR23 meeting in Montreal
Great multidisciplinary discussions 👏
Key message for me ➡️ time is ripe for an RCT comparing a surgical to a non surgical strategy in the era of immunotherapy
#ELIXR23 is not done. Day 2 well underway with @finn_corinne discussing important quality of life implications for early stage NSCLC.
Day 1 of the inaugural #ELIXR23 . Great science, new friends, aspirational ideas . Improving hope for NSCLC #LCSM @DoctorJSpicer @NormandBlais
Pros and cons, without debate, of neo-adjuvant vs adjuvant therapies in NSCLC as per @BorisSepesi and #DrPaulaUgalde . Major changes in the world needed to bring benefits to all patients #ELIXR23
Last Seen Hashtags on Sotwe
ธี่หยด2
Seen from Argentina
kigurumi #bondage
Seen from Malaysia
伺候做爱
Seen from United States
岩澤美翠
Seen from Colombia
explicitcryptofx
Seen from United States
iembesne
Seen from Vietnam
aphaziya
Seen from United States
singleorg
Seen from United States
コーラニキ
Seen from Brazil
monkeyapp
Seen from United States
Most Popular Users
Elon Musk 
@elonmusk
241.6M followers
Barack Obama
@barackobama
119M followers
Cristiano Ronaldo
@cristiano
114.2M followers
Donald J. Trump
@realdonaldtrump
111.8M followers
Narendra Modi
@narendramodi
107.2M followers
Rihanna
@rihanna
98.7M followers
NASA
@nasa
92.4M followers
Justin Bieber
@justinbieber
91.8M followers
KATY PERRY
@katyperry
89.9M followers
Taylor Swift
@taylorswift13
83.8M followers
Lady Gaga
@ladygaga
75.3M followers
Virat Kohli
@imvkohli
73.1M followers
Kim Kardashian
@kimkardashian
70.8M followers
YouTube
@youtube
68.8M followers
Neymar Jr
@neymarjr
66.2M followers
Bill Gates
@billgates
65M followers
Selena Gomez
@selenagomez
62.9M followers
The Ellen Show
@theellenshow
62.3M followers
CNN
@cnn
61.8M followers
X
@x
60.7M followers